Document Auto Tags
Document Information
Title: Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (E
Source: https://storage.googleapis.com/polarys-documents/uploads/bd18e00a-c1dc-47aa-9c2c-66b2a0195535.txt
Content Type: press_release
Word Count: 4205
Applied Auto Tags
| Auto Tag | Description | Extracted Value | Confidence | Applied | Actions |
|---|---|---|---|---|---|
| Executives | No description | None | N/A | N/A | |
| Communication Type | No description | Press Release | N/A | N/A | |
| CEO | No description | The most prominent company mentioned in the document is Biogen Inc. The document was published on June 12, 2025., According to multiple sources, Christopher A. Viehbacher was appointed as President and Chief Executive Officer of Biogen Inc. in November 2022 and continued in this role through June 2025. A SEC filing from June 2, 2025, specifically mentions Chris Viehbacher as the Chief Executive Officer., Christopher Viehbacher | N/A | N/A | |
| Company | No description | Biogen | N/A | N/A | |
| CEO | No description | Priya Singhal | N/A | N/A |
About Auto Tags
Automatic Extraction
Auto tags use AI to automatically extract specific information from this document based on predefined rules.
Re-apply Tags
You can re-apply auto tags to get updated extractions if the auto tag rules have been modified.
Remove Tags
Remove individual auto tags or use "Remove All Tags" to bulk remove all applied tags at once.